How is the UK’s planned exit from the European Union affecting all aspects of pharma, medtech, and medical devices? Explore the entirety of Brexit’s influence, including its implications for business strategies, clinical trials, drug approvals, and beyond.
Cell and gene therapy
Stay on the leading edge of what’s happening in the quickly evolving area of cell and gene therapy. Explore the latest information on policy making, financing and deal trends, trends in personalized medicine, CAR-T therapies, and more.
Clinical trials optimization
Hot Topics is your hub for recent information on all aspects of clinical trials optimization, gathered from across a wide array of Pharma Intelligence sources. Get vital facts on trends and events affecting clinical trials, like regulation, partnerships and M&A activity, clinical landscapes for diseases and drugs, and more.
Get insights into the latest deals and deal trends from Pharma Intelligence. Understand the implications of recent deals as they relate to drug development, reimbursement, and beyond.
Stay up to date on activities at the US Food and Drug Administration, with resources on topics ranging from drug approvals, to policy and regulation, to clinical trials, and beyond, with a comprehensive compendium of essential Hot Topics resources.
Understand the promising and fast-growing field of immuno-oncology, with current detailed reports, videos, whitepapers, and other vital resources that bring you to the leading edge of this important area.
Hot Topics medtech coverage includes analysis, news, and other vital resources. Explore topics like Brexit’s influence on medical device registration, medtech reimbursement developments, EU MDR implementation, and much more.
For the latest FDA approvals, deal trends, clinical trial updates, emerging reimbursement issues, etc. on the fast-growing field of personalized medicine, turn to the crucial content from Pharma Intelligence.
Access essential information regarding global reimbursement issues, from Medtech Insight, In Vivo, Datamonitor Healthcare, Pink Sheet, Scrip, and others to understand the implications on your business.
Stay up to date and explore the repercussions of the US government partial shutdown, from the effects of interrupted FDA activities, to the ramifications of a cease in operations at the US Patent and Trademark Office, and beyond.